Precision BioSciences (DTIL) Tops Q4 EPS by 105c
Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of $1.05. Revenue for the quarter came in at $34 million.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
